Valuation: Motus GI Holdings, Inc.

Market Cap 1.44K 1.25K 1.17K 1.07K 2.02K 137K 2.04K 13.67K 5.36K 68.44K 5.4K 5.28K 228K P/E 2022
-0.15x
P/E 2023 -0.08x
Enterprise Value -2.49M -2.16M -2.02M -1.85M -3.49M -237M -3.54M -23.66M -9.28M -118M -9.34M -9.14M -394M EV / Sales 2022
2.2x
EV / Sales 2023 -0.45x
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
1 day+9,900.00%
1 week+9,900.00%
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0.1
1 year 0
Extreme 1.0E-6
0.1
3 years 0
Extreme 1.0E-6
10.05
5 years 0
Extreme 1.0E-6
272.85
10 years 0
Extreme 1.0E-6
3,198
Manager TitleAgeSince
President - 2024-07-30
Comptroller/Controller/Auditor 43 2018-12-31
Sales & Marketing - -
Director TitleAgeSince
Director/Board Member - 2024-07-30
Date Insider Type Main position Quantity % Market Cap.
3/5/24 Free

Director

23,205 1.5000%
3/5/24 Free

Chief Executive Officer

23,205 1.5000%
3/5/24 Free

Director

23,205 1.5000%
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%+9,900.00%-.--%-100.00% 719
+0.38%+0.56%+29.20%+5.72% 214B
+0.16%+1.94%+2.46%-21.50% 141B
-0.40%+5.88%-21.17%+20.82% 132B
+3.27%+7.17%-52.11%-2.80% 71.45B
+0.39%+2.76%+13.62%+12.28% 51.48B
+0.96%+7.38%-14.27%-18.88% 50.15B
+0.16%+1.90%+24.83%+11.91% 39.92B
-0.08%+5.10%+43.92%+37.88% 39.24B
-0.35%+7.04%-20.40%+24.54% 32.2B
Average +990.22%+3.84%+0.61%-3.00% 77.15B
Weighted average by Cap. +0.27%+3.41%+2.77%+4.14%

Financials

2022 2023
Net sales 592K 514K 481K 440K 831K 56.39M 842K 5.63M 2.21M 28.18M 2.22M 2.17M 93.78M 319K 277K 259K 237K 448K 30.39M 453K 3.03M 1.19M 15.18M 1.2M 1.17M 50.53M
Net income -18.6M -16.14M -15.11M -13.82M -26.1M -1.77B -26.44M -177M -69.38M -885M -69.82M -68.31M -2.95B -12.87M -11.17M -10.46M -9.56M -18.06M -1.23B -18.29M -122M -48M -612M -48.31M -47.26M -2.04B
Net Debt -2.61M -2.26M -2.12M -1.94M -3.66M -248M -3.7M -24.77M -9.72M -124M -9.78M -9.57M -413M -2.49M -2.16M -2.02M -1.85M -3.49M -237M -3.54M -23.67M -9.29M -119M -9.35M -9.15M -394M
Logo Motus GI Holdings, Inc.
Motus GI Holdings, Inc. is a medical technology company. It has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles.
Employees
15
Date Price Change Volume

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MOTS Stock